Share

Intuitive Surgical Q2 profit beats estimates; shares surge

Company has a market cap of $25,521 M.

Advertisement

ISRG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $195.5 million. Intuitive Surgical has a 12 month low of $447.00 and a 12 month high of $681.59.

The total money flow in Intuitive Surgical (ISRG) was negative ($17.93 million), which signals selling by the traders on Mondays session. The company had revenue of $670.10 million for the quarter, compared to analysts expectations of $642.46 million. During the same quarter in the previous year, the company posted $4.57 EPS. On average, 14 analysts polled by Thomson Reuters expected the company to report profit per share of $4.97 for the quarter.

In a different news, on Jun 3, 2016, Salvatore Brogna (EVP – Product Operations) sold 600 shares at $630.96 per share price. Early Tuesday, J&J posted a Q2 earnings beat, and Johnson & Johnson stock hit a record high Tuesday, closing up 1.7% at 125.25. Following the completion of the sale, the senior vice president now owns 133 shares of the company’s stock, valued at $83,704.88. Also, Director Eric H. Halvorson sold 5,688 shares of the firm’s stock in a transaction on Friday, April 22nd. The stock was sold at an average price of $637.75, for a total value of $5,212,330.75. Tredje AP fonden now owns 2,403 shares of the company’s stock valued at $1,312,000 after buying an additional 39 shares during the period. Growth in procedures in China was also strong in the reported quarter.

Wedbush analyst, Tao Levy, weighed in on Intuitive Surgical, Inc. Finally, Gulf International Bank UK Ltd raised its stake in Intuitive Surgical by 2.8% in the fourth quarter. Barclays PLC reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Saturday, June 18th. Intuitive Surgical has an average rating of “Buy” and a consensus target price of $640.08. Deferred revenue (current) was $225.6 millions for the three-month period ended 2015-12-31. The company has a consensus rating of “Buy” and an average price target of $672.42.

A number of large investors recently bought and sold shares of ISRG. IFP Advisors Inc now owns 284 shares of the company’s stock valued at $171,000 after buying an additional 9 shares in the last quarter. Alliancebernstein L.P. boosted its position in Intuitive Surgical by 15.3% in the fourth quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its stake in Intuitive Surgical by 35.6% in the second quarter. Advisor Partners LLC now owns 477 shares of the company’s stock valued at $287,000 after buying an additional 44 shares in the last quarter.

Advertisement

In a pre-earnings research note, Leerink analyst Richard Newitter said Intuitive was increasingly benefiting from the “next leg of growth” for its da Vinci Xi system, launched in 2014. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System is created to provide its operating surgeon with intuitive control, range of motion, fine tissue manipulation capability and three dimensional (3-D), high-definition (HD) vision while simultaneously allowing the surgeon to work through the small ports of MIS.

A surgeon views three-dimensional image on da Vinci Xi Surgical System made by Intuitive Surgical during demonstrated of surgery robot at Palomar Medical Center in Escondido California